Oncoguía de cáncer renal 2023
Renal cell carcinoma (RCC) stands for 2-3 % of all neoplasms worldwide. The most important risk factors identified for RCC are obesity, hypertension, type 2 diabetes mellitus, and tobacco use. Nowadays, more than 50 % of RCCs are detected incidentally. There are multiple therapeutic strategies to treat RCC, ranging from active surveillance or nephrectomy for localized disease to combinations of targeted therapies and immunotherapy for patients with advanced disease.
Authors
- Nora Sobrevilla Moreno
- Anna Scavuzzo
- Juan B. Gutiérrez (ORCID: https://orcid.org/0000-0002-0627-5035)
- Miguel A. Rı́os (ORCID: https://orcid.org/0000-0001-8937-9560)
- Miguel Ángel Álvarez-Avitia (ORCID: https://orcid.org/0009-0002-1632-0298)
- Gabriela Alamilla García
- Salvador Gutiérrez Torres
- Iván Calvo
- Galileo González Conchas
- José Alberto Caballero Vega
Institutions
- Instituto Nacional de Cancerología (MX)
Publication Details
- Journal
- Latin American Journal of Clinical Sciences and Medical Technology
- Published
- 2024-11-04
- DOI
- https://doi.org/10.34141/ljcs2514402
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00